← Leaderboards
Brian P Head
University Of California, San Diego
$1,384,726
Attributed
$1,384,726
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $358.6K · FY2012–25$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,384,726 · 1
VA$0 · 4
By mechanism
R01$1,384,726 · 1
I01$0 · 2
I21$0 · 1
IK6$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Diego
Same institution · by research overlap
- Mark H Tuszynski$42,403,260
- Roger Philip Levy$1,029,986
- David M Roth$6,970,274
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposCaveolin 1Signal TransductionScaffolding ProteinMembrane MicrodomainsGrowthSynapsesBrainNeuronsIn VivoOverexpressionS DiseaseMembraneMediatingMemoryCognitive FunctionLearningCaveolinsVeteransNeuronal PlasticityAmyotrophic Lateral SclerosisHippocampus (Brain)Membrane LipidsPromoter
Grant awards (21)
BLR&D MERIT REVIEW RESEARCH CAREER SCIENTIST AWARD APPLICATION$0
IK6 · FY2025 · VA · contact PI
BLR&D MERIT REVIEW RESEARCH CAREER SCIENTIST AWARD APPLICATION$0
IK6 · FY2024 · VA · contact PI
Caveolin-Mediated Neuroplasticity in Alzheimer's Disease and in Human Neurons Harboring EOFAD Mutations$0
I01 · FY2024 · VA · contact PI
Caveolin-Mediated Neuroplasticity in Alzheimer's Disease and in Human Neurons Harboring EOFAD Mutations$0
I01 · FY2023 · VA · contact PI
BLR&D MERIT REVIEW RESEARCH CAREER SCIENTIST AWARD APPLICATION$0
IK6 · FY2023 · VA · contact PI
Neuron-targeted caveolin-1 as a gene therapy for ALS$0
I21 · FY2022 · VA · contact PI
Caveolin-Mediated Neuroplasticity in Alzheimer's Disease and in Human Neurons Harboring EOFAD Mutations$0
I01 · FY2022 · VA · contact PI
Neuron-targeted caveolin-1 as a gene therapy for ALS$0
I21 · FY2021 · VA · contact PI
Caveolin-Mediated Neuroplasticity in Alzheimer's Disease and in Human Neurons Harboring EOFAD Mutations$0
I01 · FY2021 · VA · contact PI
Caveolin-mediated neuronal signaling in differentiated adult human neuronal stem cells and the aging brain$0
I01 · FY2020 · VA · contact PI
Neuron-targeted caveolin-1 as a gene therapy for ALS$0
I21 · FY2019 · VA · contact PI
Caveolin-mediated neuronal signaling in differentiated adult human neuronal stem cells and the aging brain$0
I01 · FY2019 · VA · contact PI
Caveolin-mediated neuronal signaling in differentiated adult human neuronal stem cells and the aging brain$0
I01 · FY2018 · VA · contact PI
Caveolin-mediated neuronal signaling in differentiated adult human neuronal stem cells and the aging brain$0
I01 · FY2017 · VA · contact PI
Neuronal-targeted caveolin-1 as a therapy for traumatic brain injury$347,239
R01 · FY2015 · NS · contact PI
Neuronal-targeted caveolin-1 as a therapy for traumatic brain injury$343,767
R01 · FY2014 · NS · contact PI
Neuron-Targeted Caveolin-1 as a Therapy for Age-Related Neurodegeneration$0
I01 · FY2014 · VA · contact PI
Neuronal-targeted caveolin-1 as a therapy for traumatic brain injury$335,085
R01 · FY2013 · NS · contact PI
Neuron-Targeted Caveolin-1 as a Therapy for Age-Related Neurodegeneration$0
I01 · FY2013 · VA · contact PI
Neuronal-targeted caveolin-1 as a therapy for traumatic brain injury$358,635
R01 · FY2012 · NS · contact PI
Neuron-Targeted Caveolin-1 as a Therapy for Age-Related Neurodegeneration$0
I01 · FY2012 · VA · contact PI